The Influence of St. John's Wort on the Pharmacokinetics and Protein Binding of Imatinib Mesylate.

扫码查看

原文链接

NSTL

外文摘要：Study Objective. To determine the effect of St. John's wort on the pharmacokinetics of imatinib mesylate. Design. Open-label, complete crossover, fixed-sequence, pharmacokinetic study. Setting. Clinical research center. Subjects. Ten healthy adult volunteers. Intervention. Single 400-mg oral doses of imatinib were administered before and after 2 weeks of treatment with St. John's wort 300 mg 3 times/day. Measurements and Main Results. The pharmacokinetics of imatinib were significantly altered by St. John's wort, with reductions of 32% in the median area under the concentration-time curve from time zero to infinity (p=0.0001), 29% in maximum observed concentration (p=0.005), and 21% in half-life (p=0.0001). Protein binding ranged from 97.7-90.3% (mean 94.9%), was concentration independent, and was not altered by St. John's wort. Therapeutic outcomes of imatinib have been shown to correlate with both dose and drug concentrations. Conclusion. Coadministration of imatinib with St. John's wort may compromise imatinib's clinical efficacy.

外文关键词：

IMATINIBST. JOHN'S WORT EXTRACTConcentrationProtein Binding蛋白质结合

作者：

Smith P、Bullock JM、Booker BM、Haas CE、Berenson CS、Jusko WJ

展开 >

作者单位：

School of Pharmacy and Pharmaceutical Sciences, University of Buffalo

Roswell Park Cancer Institute

Clinical Research Center, Veteran's Administration Western New York Health Care System.

Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai 200032,China

展开 >

出版年：

2004

Pharmacotherapy.

ISSN：0277-0008

年,卷(期)：2004.24(11)